What is the role of quinidine in the treatment of pediatric atrial flutter?

Updated: Feb 04, 2019
  • Author: M Silvana Horenstein, MD; Chief Editor: Syamasundar Rao Patnana, MD  more...
  • Print
Answer

According to a legal precedent, patients with Mustard repair of transposition of the great vessels and sick sinus syndrome should not receive quinidine without a previously implanted pacemaker. However, quinidine is now recognized to have a detrimental adverse effect profile in general, and it is essentially no longer used in the treatment of rhythm disorders following congenital heart disease. Disagreement surrounds whether this recommendation should be extrapolated to other antiarrhythmics and other forms of repaired congenital heart disease.

See Atrial Flutter and Emergent Management of Atrial Flutter for more information on these topics.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!